Psychedelics have been making waves in the medical and scientific community, with ongoing research and developments in the field. In this article, we highlight some of the key headlines from the last two weeks of February 2024.
Research plays a crucial role in understanding the potential benefits and risks of psychedelic substances. Some of the notable research projects include the validation of the Psychedelic Predictor Scale, a study on psilocybin-assisted psychotherapy for treatment-resistant depression, and the development of a digital intervention for psychedelic preparation. Additionally, a symposium organized by Harvard’s Petrie Flom Center focused on Critical Psychedelic Studies, aiming to correct the hype surrounding these substances.
In the realm of education and awareness, several articles and resources have been published to help individuals navigate the world of psychedelics. Topics range from predicting readiness for a psychedelic experience to understanding the differences between macrodosing and microdosing. There are also discussions on evidence-based drug policy, the risks of underground psychedelic training programs, and the potential benefits of psychedelic breathwork.
On the business front, companies like Optimi Health and Filament Health have made significant announcements related to psychedelic products and services. Optimi Health closed a non-brokered private placement, while Filament Health completed the first export of botanical psilocybin to Israel. Silo Wellness also made headlines with an extension of the Kaya Holdings-NUGL LOI and an annual filings delay.
Upcoming events and initiatives in the psychedelic space include talks on drug policy reform, psychedelic therapy practices, and the potential role of psychedelics in substance use disorder treatment. From online courses on drug testing and harm reduction to symposiums and panel discussions, there are many opportunities for individuals to learn and engage with the evolving landscape of psychedelics.
Overall, the psychedelic headlines roundup for the last two weeks of February 2024 showcases the diverse range of research, education, business, and advocacy efforts taking place in this rapidly growing field. As interest and acceptance of psychedelics continue to increase, it is essential to stay informed and engaged with the latest developments to ensure responsible and informed use of these substances.
